MedMira Inc.

MedMira Inc.

MMIRF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$24.56M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
MedMira Inc.MedMira Inc.-8-11%--0.7
$-0.01

Current Fair Value

132.3% downside

Overvalued by 132.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$24.56 Million
Enterprise Value$42.61 Million
Earnings per Share$0
Beta0.76
Outstanding Shares697,666,127

Return

Return on Equity11.04%ROE
Return on Assets-79.58%
Return on Invested Capital8.84%

Valuation & Multiples

P/E Ratio-7.95P/E Ratio
PEG15.65PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.04Price to Book Ratio
Enterprise Value to Revenue115.01
Enterprise Value to EBIT-21.92
Enterprise Value to Net Income-16
Total Debt to Enterprise0.42
Debt to Equity-0.74Debt to Equity

Revenue Sources

No data

Next Earnings Call

Expected Date
November 27, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About MedMira Inc.

52 employees
CEO: Hermes Chan

MedMira Inc. is a biotechnology company focused on the research, development, manufacturing, and global commercialization of rapid diagnostic solutions and related technology platforms. Its operations span North America, Europe, the Asia...

Questions & Answers